 Serological evidence infection Helicobacter pylori gastrointestinal intolerance non-steroidal anti-inflammatory drug NSAID treatment rheumatoid arthritis Specific antibodies spiral gastric organism Helicobacter pylori HP detectable patients rheumatoid arthritis complement fixation test CFT enzyme-linked immunosorbent assay ELISA frequency comparable normal age-matched population Presence antibodies previous history peptic ulcer disease PUD severity NSAID-related dyspeptic symptoms latter multiple drug intolerance short term prospective NSAID toxicity data little relationship ulceration HP carriage result HP definite role pathogenesis symptomatic PUD chronic NSAID usage important implications ulcer prophylaxis patients